Open:Close: Menu En Español
1-888-484-5529
Toll Free
212-750-1200
In New York
call or email for a free consultation
email us
for fast
answers
Open:Close: Our Practice Areas

POSTS TAGGED "dangerous drugs"

Blood-Thinner Pradaxa Linked to Over 500 Deaths in Just Two Years

After two years on the market, Pradaxa has become an extremely successful product. The drug functions as a blood-thinning agent and competes with another frequently prescribed drug, warfarin. Blood-thinning drugs help prevent blood clotting and strokes. The Food and Drug Administration says that 725,000 patients have taken Pradaxa, including 17 percent of atrial fibrillation patients.

However, experts are now reporting strong indications that Pradaxa is actually a very dangerous drug. Like other drugs with dangerous side effects, Pradaxa is starting to attract more and more criticism, leading to lawsuits from injured patients and the families of deceased victims.

Fungal Meningitis: Contamination Fears Spread to More Bad Drugs

 As if 28 victims dead and close to 400 more infected with fungal meningitis were not bad enough, the Food and Drug Administration identified even more contaminated drugs from the same pharmacy. This could point to even more potential claims against the New England Compounding Center if authorities link other cases to these drugs.

On top of the contaminated epidural steroids that caused the national fungal meningitis outbreak, the FDA is pointing to more defective drugs. These include several batches of another steroid and a heart surgery-related solution called cardioplegia. While the meningitis cases resulted from a fungal contamination, these drugs contain dangerous bacterial infections.

Off-Label Marketing of Drugs Leads to More Trouble for Health Giant J&J

 Johnson & Johnson (J&J), the world's second-largest manufacturer of health products, has been the subject of an ongoing federal civil investigation involving the company's marketing practices for its antipsychotic drug Risperdal.

Reports of J&J misleading over 6,000 doctors in Arkansas about the effectiveness of Risperdal comes on the heels of J&J's current negotiations with the federal government to settle for its off-label marketing of the drug.

Unauthorized marketing of drugs is a common problem across the country, with companies like Johnson & Johnson marketing them for "off-label" purposes. Although doctors are allowed to prescribe drugs for off-label purposes, companies that make the drugs are required by law to only market them for uses that are approved by the U.S. Food and Drug Administration.

Marketing drugs for off-label purposes can harm people who use medications. Taking medications for off-label purposes is often dangerous and ineffective, resulting in serious, unintended consequences. It is important that patients talk to their doctors about the intended purposes of the medications they take. And as more information comes to light about the injury risks associated with medications such as these, it may be possible to file a defective drug lawsuit for damages.

Contact trolman, glaser & lichtman, PC

747 Third Avenue, 23rd Floor | New York, NY 10017|Phone: 212-750-1200|Toll-Free: 1-888-484-5529|Fax: 212-980-4011|Email